Sort
16,300 grants matching “fatty liver disease”
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2022 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2020 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2021 · HL
Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State
$501,518Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2015 · HL
Diet and the CPT1A arctic variant: Impact on the Health of Alaska Native Children
$501,464David M Koeller · Oregon Health & Science University · R01 · FY2019 · HD
Metabolic impact of fructose restriction in obese children
$501,437Jean-Marc Schwarz · Touro University Of California · R01 · FY2013 · DK
Toward a quantitative understanding of metabolic homeostasis
$501,375Denis Vasilievich Titov · University Of California Berkeley · R35 · FY2024 · GM
Identifying genes required for digestive physiology and lipid metabolism
$501,033Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2015 · DK
A novel pathway controls liver injury in NASH
$501,032Peng Zhao · University Of Texas Hlth Science Center · R01 · FY2024 · DK
Effect of Alcohol on Obesity Related Liver Disease
$500,984Arun J Sanyal · Virginia Commonwealth University · R01 · FY2012 · AA
The molecular mechanisms of nutrient- and stress-dependent mTORC1 regulation mediated by human Sestrin2.
$500,978Uhn-Soo Cho · University Of Michigan At Ann Arbor · R01 · FY2016 · DK
Tumor Detection and Classification using QUS Technology's Structure Function
$500,727William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Small molecule inhibitors of LMPTP: an obesity drug target
$500,608Nunzio Bottini · University Of California, San Diego · R01 · FY2020 · DK
Role of SerpinB1 in beta cell growth
$500,598Rohit N. Kulkarni · Joslin Diabetes Center · R01 · FY2015 · DK
Hepatocyte Abca1, cholesterol trafficking, and lipid mobilization
$500,496John S Parks · Wake Forest University Health Sciences · R01 · FY2019 · HL
Clinical Research on Nonalcoholic Fatty Liver Disease
$500,465Joel Edward Lavine · University Of California, San Diego · U01 · FY2009 · DK
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
$500,441Loning None Fu · Baylor College Of Medicine · R01 · FY2021 · CA
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population
$500,383Joanne E Curran · University Of Texas Rio Grande Valley · R01 · FY2024 · DK
Natriuretic peptide and cGMP signaling in adipose tissue and energy metabolism
$500,295Sheila Collins · Vanderbilt University Medical Center · R01 · FY2023 · DK
Insulin Regulation of Hepatic Function via Zone-Specific Transcriptional Programs
$500,253Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2025 · DK
Control of PGC1alpha Translation and Function
$500,197Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2019 · DK
Insulin Regulation of Hepatic Function via Zone-Specific Transcriptional Programs
$500,167Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2023 · DK
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$500,089Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2025 · CA
HIV Antiretroviral Therapy and Hepatic Injury
$500,044Kenneth E Sherman · University Of Cincinnati · R01 · FY2019 · AI
A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes
$500,000Anita P Courcoulas · University Of Pittsburgh At Pittsburgh · RC1 · FY2009 · DK